317450 — Myung In Pharm Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapNeutral

Annual income statement for Myung In Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS
Standards:	IFRS	IFRS	IFRS
Status:	Final	Final	Final
Revenue
Total Revenue	225,828	242,338	269,435
Cost of Revenue
Gross Profit	143,549	149,888	165,195
Selling / General / Administrative Expenses
Depreciation and Amortization
Total Operating Expenses	149,926	158,719	176,680
Operating Profit	75,903	83,618	92,754
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	81,817	92,061	88,075
Provision for Income Taxes
Net Income After Taxes	57,434	74,512	68,671
Net Income Before Extraordinary Items
Net Income	57,434	74,512	68,671
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	57,434	74,512	68,671
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	3,934	5,104	4,736
Dividends per Share